First Patients Dosed in Final Cohort of HER-096 Parkinson’s Phase 1b Trial
Details : HER-096 is a CDNF mimetic that has the potential to protect against the neuronal degeneration and cell death that cause the symptoms of Parkinson’s disease.
Product Name : HER-096
Product Type : Other Large Molecule
Upfront Cash : Inapplicable
May 13, 2025
Inoviv Secures Investment to Enhance Quantitative Proteomics
Details : The net proceeds will be used to accelerate company's drug development pipelines, including HER-096, developed from neurotrophic factor CDNF, a groundbreaking approach to Parkinson's disease.
Product Name : HER-096
Product Type : Other Large Molecule
Upfront Cash : Undisclosed
January 30, 2024
Reset All
